Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: OmegAD (Omega-3 and Alzheimer's Disease) [NA]
This entry notes that the OmegAD study evaluating omega-3 fatty acids for Alzheimer's disease has completed enrollment/status, with no furth…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Effects of Simvastatin on Biomarkers [Phase 4]
Phase 4 clinical trial evaluating the effects of simvastatin on biomarkers in Alzheimer's disease has completed and results are posted.
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of the PET tracer [18F]NAV4694 for detecting cerebral beta-amyloid, using postmo…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Clinical Pathway for Alzheimer's Disease in China (CPAD)
This update notes that the CPAD (Clinical Pathway for Alzheimer's Disease in China) trial conducted by Peking University has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers [Phase 1]
Phase 1 study evaluating the pharmacokinetics, dose proportionality, food effect and repeat-dose safety of rosiglitazone XR in healthy volun…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease [Phase 1]
A Phase 1 clinical study evaluating single and repeat dosing of GSK933776 in patients with Alzheimer's disease. The trial, sponsored by Glax…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease [Phase 1]
A Phase 1 study evaluated RO7105705 in healthy participants and in individuals with mild-to-moderate Alzheimer's disease; the trial has comp…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY) [Phase 2]
Phase 2 study evaluating the efficacy and safety of MABT5102A in patients with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial evaluating the anti-amyloid monoclonal antibody MABT5102A in mild-to-moderate Alzheimer's disease has completed the…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease [Phase 1]
A bridging Phase 1 study of GSK239512 in patients with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Effects of an Anti-Inflammatory Drug in Alzheimer's Disease [Phase 1]
A Phase 1 clinical trial evaluating an anti-inflammatory drug for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: PET Imaging of Brain Amyloid Using [11C]MeS-IMPY [Phase 1]
Phase 1 trial update evaluating PET imaging of brain amyloid using the radiotracer [11C]MeS-IMPY in individuals with Alzheimer's disease and…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder
The clinical trial evaluating age- and Alzheimer's disease-related memory disorders has completed (sponsored by NIMH), involving conditions …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
A completed clinical trial evaluating MRI imaging of amyloid plaques in people with and without memory problems to study Alzheimer's disease…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment [Phase 1]
Phase I study evaluating safety, tolerability and pharmacokinetics of an investigational M1 muscarinic receptor agonist for cognitive impair…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Serotonergic Pharmacotherapy for Agitation of Dementia [Phase 3]
A Phase 3 clinical trial evaluating a serotonergic treatment for agitation in dementia has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient [Phase 1]
A Phase 1 trial assessing modulation of Abeta levels by GSK933776 in patients with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic study evaluating E2609 and its metabolites in subjects with mild and moderate hepatic impairment compared with healt…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers [Phase 1]
Phase 1 drug-drug interaction study of GSK2647544 RD in healthy young and elderly volunteers was terminated.
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Comparison of PET Amyloid Imaging in Japanese and Western Subjects [Phase 2]
Phase 2 trial update comparing PET amyloid imaging in Japanese and Western subjects has been completed with results posted in 2017, focusing…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer Patients [NA]
Clinical trial evaluating combined transcranial magnetic stimulation (TMS) and cognitive training in Alzheimer's disease; results were poste…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease [Phase 2]
A Phase 2 trial evaluating the safety and tolerability of PQ912 in people with early Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab [Phase 2]
Pfizer's Phase 2 study evaluating the long-term safety and efficacy of subcutaneous bapineuzumab in Alzheimer's disease was terminated, with…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy [Phase 2]
This document reports the completion of a Phase 2 study evaluating RO4602522 in participants with moderate Alzheimer's disease on background…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Memantine Treatment in Alzheimer's Disease Patients [Phase 4]
Phase 4 clinical trial update evaluating memantine in patients with Alzheimer's disease; current trial status is unknown.